Pluri To Manufacture Kadimastem`s Cell Therapy Product Candidates
18 Jul 2024 //
GLOBENEWSWIRE
Kadimastem Receives Approval of Patent Registration for Its Cell Selection
28 Sep 2022 //
PRNEWSWIRE
Kadimastem Granted a Patent in Israel for the Directed Differentiation
09 Mar 2021 //
PRNEWSWIRE
Kadimastem Granted a Patent in Israel for the Directed of Astrocytes
09 Mar 2021 //
PRNEWSWIRE
Kadimastem Announces Encouraging Results of Cohort B of its Phase 1/2a AstroRx®
15 Dec 2020 //
PRNEWSWIRE
Kadimastem Reports +ve Interim Results of Cohort B AstroRx® Ph 1/2a in ALS
03 Aug 2020 //
PRNEWSWIRE